Employees: NN (None)Legal category: SCA (commandite par actions)Size: PMECreation date: 2019-07-01 (6 years)Status: ActiveBusiness sector: Conseil pour les affaires et autres conseils de gestionLocation: MANTES-LA-JOLIE (78200), Yvelines
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EXPERTISE-PATIENT : revenue, balance sheet and financial ratios
EXPERTISE-PATIENT is a French company
founded 6 years ago,
specialized in the sector Conseil pour les affaires et autres conseils de gestion.
Based in MANTES-LA-JOLIE (78200),
this company of category PME
shows in 2021 a revenue of 15 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EXPERTISE-PATIENT (SIREN 852004795)
Indicator
2021
Revenue
15 422 €
Net income
11 351 €
EBITDA
12 412 €
Net margin
73.6%
Revenue and income statement
In 2021, EXPERTISE-PATIENT achieves revenue of 15 k€. After deducting consumption (0 €), gross margin stands at 15 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 12 k€, representing 80.5% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 11 k€, i.e. 73.6% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2021)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
15 422 €
Gross margin (2021)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
15 422 €
EBITDA (2021)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
12 412 €
EBIT (2021)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
12 135 €
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
11 351 €
EBITDA margin (2021)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
56.0%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 75.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.98%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
11.561%
Cash flow / Revenue (2021)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
75.405%
Repayment capacity (2021)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.212
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
Debt ratio
16.98
Financial autonomy
11.561
Repayment capacity
0.212
Cash flow / Revenue
75.405%
Sector positioning
Debt ratio
16.982021
2021
Q1: 0.0
Med: 5.69
Q3: 57.88
Average
In 2021, the debt ratio of EXPERTISE-PATIENT (16.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
11.56%2021
2021
Q1: 6.7%
Med: 39.89%
Q3: 74.08%
Average
In 2021, the financial autonomy of EXPERTISE-PATIENT (11.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.21 years2021
2021
Q1: 0.0 years
Med: 0.0 years
Q3: 1.06 years
Average
In 2021, the repayment capacity of EXPERTISE-PATIENT (0.21) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 436.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
436.492
Interest coverage (2021)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.0
Liquidity indicators evolution EXPERTISE-PATIENT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
Liquidity ratio
436.492
Interest coverage
0.0
Sector positioning
Liquidity ratio
436.492021
2021
Q1: 138.88
Med: 286.2
Q3: 706.78
Good
In 2021, the liquidity ratio of EXPERTISE-PATIENT (436.49) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.0x2021
2021
Q1: 0.0x
Med: 0.0x
Q3: 0.2x
Average
In 2021, the interest coverage of EXPERTISE-PATIENT (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 12 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 25 days. Favorable situation: supplier credit is longer than customer credit by 13 days. WCR is negative (-87 days): operations structurally generate cash.
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
-3 714 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
12 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
25 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2021)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
-87 j
WCR and payment terms evolution EXPERTISE-PATIENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
Operating WCR
-3 714 €
Inventory turnover (days)
0
Customer payment term (days)
12
Supplier payment term (days)
25
Positioning of EXPERTISE-PATIENT in its sector
Comparison with sector Conseil pour les affaires et autres conseils de gestion
Valuation estimate
Based on 61 transactions of similar company sales
in 2021,
the value of EXPERTISE-PATIENT is estimated at
27 067 €
(range 14 937€ - 61 113€).
With an EBITDA of 12 412€, the sector multiple of 3.1x is applied.
The price/revenue ratio is 0.54x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2021
61 tx
14k€27k€61k€
27 067 €Range: 14 937€ - 61 113€
NAF 5 année 2021
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
12 412 €×3.1x
Estimation37 986 €
21 341€ - 89 506€
Revenue Multiple30%
15 422 €×0.54x
Estimation8 343 €
3 396€ - 13 049€
Net Income Multiple20%
11 351 €×2.5x
Estimation27 860 €
16 241€ - 62 229€
How is this estimate calculated?
This estimate is based on the analysis of 61 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Conseil pour les affaires et autres conseils de gestion)
Compare EXPERTISE-PATIENT with other companies in the same sector:
Frequently asked questions about EXPERTISE-PATIENT
What is the revenue of EXPERTISE-PATIENT ?
The revenue of EXPERTISE-PATIENT in 2021 is 15 k€.
Is EXPERTISE-PATIENT profitable?
Yes, EXPERTISE-PATIENT generated a net profit of 11 k€ in 2021.
Where is the headquarters of EXPERTISE-PATIENT ?
The headquarters of EXPERTISE-PATIENT is located in MANTES-LA-JOLIE (78200), in the department Yvelines.
Where to find the tax return of EXPERTISE-PATIENT ?
The tax return of EXPERTISE-PATIENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EXPERTISE-PATIENT operate?
EXPERTISE-PATIENT operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart